Profile photo Roger Schutgens

Roger Schutgens

Full Professor

Strategic program(s):

Biography

Roger Schutgens is a Consultant Haematologist at the University Medical Centre Utrecht. His main responsibilities include care, research and education in the area of benign hematology and clotting diseases. Prof. Schutgens is the Head of at the Van Creveldkliniek, a national expertise center for rare and/or inherited benign hematologic disorders, thrombosis and haemostasis. He completed his medical degree from Catholic University Leuven, Leuven, Belgium and he completed his PhD from Utrecht University, Utrecht, The Netherlands. Prof. Schutgens areas of focus include patients predisposed to bleeding, congenital abnormalities of platelets and hypercoagulable conditions.

Research groups

Thrombosis and hemostasis

Research aim

We aim to advance knowledge in the field of thrombosis and hemostasis and translate scientific findings into improved clinical care and outcomes for patients affected by blood clotting disorders.

Go to group

Hemophilia, Von Willebrand disease and allied coagulation disorders

Research aim

To improve care for patients with (inherited) bleeding disorders by studying the optimum outcome parameters in a multidisciplinary setting, including physiotherapy and nursing interventions, as well as novel treatment modalities.

Go to group

Recent publications

The use of light transmission aggregometry for monitoring platelet transfusion response in a small case cohort of Glanzmann thrombasthenia patients Karlijn H G Rutten, Olga Tsiamita, Sean Platton, Mathieu Fiore, Rolf T Urbanus, Suthesh Sivapalaratnam, Roger E G Schutgens
Platelets, 2026, vol. 37, p.1-7
Plasma proteomics does not identify biomarkers of venous thromboembolism recurrence during and after anticoagulation Eva R Smit, Geke C Poolen, Tirsa T van Duijl, Suzanne C Cannegieter, Diana Muñoz Sandoval, Carmen van der Zwaan, Geert-Jan Geersing, Arie J Hoogendijk, Roger E G Schutgens, Rolf T Urbanus, Maartje van den Biggelaar
Journal of thrombosis and haemostasis : JTH, 2025, vol. 24, p.1365-1376
High bleeding rates in δ-storage pool disease during surgeries and deliveries Elleke van Heerwaarde, Annick de Moor, Albert Huisman, Rolf Urbanus, Idske Kremer Hovinga, Roger Schutgens,
Research and practice in thrombosis and haemostasis, 2025, vol. 9
Preclinical assessment of two FcγRI-specific antibodies that competitively inhibit immune complex-FcγRI binding to suppress autoimmune responses Tosca Holtrop, Arianne M Brandsma, Louris J Feitsma, Steffen Krohn, Petra Moerer, Frederique van den Haak, Anouk Versnel, Leonie Voss, Elsemieke M Passchier, Maaike Nederend, J H Marco Jansen, Anouk G van Mourik, Rolf T Urbanus, Diane van der Woude, Roger E G Schutgens, Rene E M Toes, Bert J C Janssen, Anja Lux, Kevin Budding, Matthias Peipp, Jeanette H W Leusen
Nature Communications, 2025, vol. 16
European Management of Glanzmann's Thrombasthenia Mathieu Fiore, Andrea Artoni, Robert Klamroth, Mary Mathias, Roger Schutgens, Roseline d'Oiron,
Haemophilia, 2025, vol. 31, p.1261-1270
Management of pregnancy and childbirth in Glanzmann thrombasthenia Karlijn H.G. Rutten, Olga Tsiamita, Quentin Van Thillo, Priyanka Raheja, Mandeep Kaler, Karin P.M. van Galen, Matthew Hogg, Louise Bowles, Roger E.G. Schutgens, Suthesh Sivapalaratnam
British Journal of Haematology, 2025, vol. 207, p.1702-1708

External positions

1% maatschapsaandeel - geen - Huisartsenpraktijk Voordorp

zie bijlage - inhoudsdeskundige - Zorginstituut Nederland